1Alberti KG, Zimmet PZ. Definition, diagnosis and classification ofdiabetes mellitus and its complications. Part 1 : diagnosis andclassification of diabetes mellitus provisional report of a WHOconsultation. Diabet Med,1998,15 :539-553.
3Engelgau MM, Narayan KM, Herman WH. Screening for type 2diabetes. Diabetes Care,2000, 23 : 1563-1580.
4American Diabetes Association. Standards of medical care indiabetes—2010. Diabetes Care,2010,33 Suppl 1 :SI 1-61.
5Harris MI,Eastman RC : Early detection of undiagnosed diabetesmellitus: a US perspective. Diabete Metab Res Rev, 2001, 16:230-236.
6Manley SM, Meyer LC, Neil HAW, et al. UKPDS 6:Complications in newly diagnosed type 2 diabetic patients and theirassociation with different clinical and biologic risk factors.Diabetes Res, 1990,13:1-11.
7Bunn HF. Evaluation of glycosylated hemoglobin diabetic patients.Diabetes, 1981,30 :613-617.
8Ahmed N,Thornalley PJ. Advanced glycalion endproducts: whatis their relevance to diabetic complications? Diabetes Obes Metab,2007,9:233-245.
9Monnier VM, Sell DR, Dai Z, et al. The role of the amadoriproduct in the complications of diabetes. Ann N Y Acad Sci,2008,1126:81-88.
10Genuth S, Sun W, Cleary P, el al. DCCT Skin Collagen AncillaryStudy Group. Glycation and carboxymethyllysine levels in skincollagen predict the risk of future 10-year progression of diabeticretinopathy and nephropathy in the diabetes control andcomplications trial and epidemiology of diabetes interventions andcomplications participants with type 1 diabetes. Diabetes,2005,54:3103-3111.
